U.S. Professional Services Stock News

NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Pharmaceutical (BMRN): Margin Surge Reinforces Bullish Narratives Despite Revenue Lag

BioMarin Pharmaceutical (BMRN) delivered a net profit margin of 16.8%, up from 11.7% a year ago, with earnings soaring 61.5% over the past twelve months compared to a five-year average annual decline of 8.5%. While revenue is forecast to climb at 6.5% per year, lagging the broader US market’s 10.1% estimate, earnings are expected to accelerate at a 21.3% annual rate, outpacing the market’s 15.6%. The balance of strong profit growth and improved margins, together with a share price of $53.49...
NYSE:NOV
NYSE:NOVEnergy Services

NOV (NOV) Margin Miss Reinforces Investor Concerns on Profitability and Dividend Sustainability

NOV (NOV) posted net profit margins of 4.4%, down from last year’s 12%. Earnings have surged by an impressive 73% per year over the past five years, and NOV has now achieved consistent profitability. While revenue is forecast to grow at a modest 1.2% annually, annual earnings are projected to increase by 9.6%. Investors are weighing the softer margins and dividend sustainability against NOV’s solid history of earnings growth and attractive valuation. See our full analysis for NOV. Next, we...
NYSE:DQ
NYSE:DQSemiconductor

Daqo New Energy (NYSE:DQ) Faces Steep Losses as Forecasts Point to 33.9% Annual Revenue Growth

Daqo New Energy (NYSE:DQ) remains unprofitable, with losses having increased by 29.6% per year over the past five years and no meaningful improvement in profit margin. Despite these continued losses, revenue is forecast to grow at a robust 33.9% annually, far outpacing the broader US market's 10.1% yearly expectation. Earnings are expected to rise by a staggering 109.84% per year. Investors are likely to focus on these rapid growth forecasts as they weigh the company’s ongoing lack of...
NasdaqGS:FTAI
NasdaqGS:FTAITrade Distributors

FTAI Aviation (FTAI) One-Off $262M Loss Weighs on Profit, Testing Bullish Growth Narratives

FTAI Aviation (FTAI) posted a 23.2% annual earnings growth forecast, eclipsing the US market’s 15.6% growth rate. Revenue is expected to expand at 13.3% per year, ahead of the market’s 10.1%. The company recently tipped into profitability and has managed to expand its net profit margin, but its latest financials were weighed down by a one-off $262 million loss. Over the past five years, annual earnings growth averaged a robust 53.7%, setting a strong backdrop for the future outlook. See our...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services (UHS) Profit Margin Improvement Reinforces Value Narrative Despite Growth Forecasts Lagging US Market

Universal Health Services (NYSE:UHS) delivered a standout year, with earnings climbing 34% over the past twelve months, well above its five-year average growth rate of 4.8% per year. Net profit margin improved to 8.1% from last year’s 6.7%, underscoring increasing profitability. While forecasts point to continued earnings and revenue growth ahead, both are expected to trail the broader US market. This keeps the stock’s position as a value play in the sector front of mind for investors. See...
NYSE:WELL
NYSE:WELLHealth Care REITs

Welltower (WELL): Profit Margin Miss Challenges Bullish Growth Narrative

Welltower (WELL) posted earnings growth of 4.9% this year, which falls below its solid 9.4% annualized pace over the past five years. Net profit margins slipped to 9.7% from 12.1% a year ago, and shares are currently trading at $179.7, notably above the estimated fair value of $170.23. Despite this, forecasts call for annual earnings growth of 24.4% and revenue to climb 14.5% per year, both comfortably ahead of the broader US market. However, questions remain about elevated valuation...
NYSE:PRI
NYSE:PRIInsurance

Does Primerica’s Five-Year 147% Surge Signal Room for Growth Despite Recent Slide?

Deciding what to do with Primerica stock right now might feel like staring at a puzzle with a few missing pieces. Over the past year, shares have slid by 4.1%, and they’re down 5.5% over the past month. Yet, if you zoom out, the long-term picture tells a very different story. Primerica is up a staggering 147.7% over the past five years. Recent news has drawn attention to how changes in the industry and consumer behaviors are affecting the dynamics for insurers, and that has rippled through...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Keurig Dr Pepper (KDP): $787 Million One-Off Loss Challenges Margin Recovery Narrative

Keurig Dr Pepper (KDP) posted average annual earnings growth of 2.8% over the past five years. However, the latest year saw earnings decline and net profit margins compress from 14.5% to 9.7%. Looking forward, revenue is forecast to grow by 3.7% per year, while earnings growth is expected to pick up to 8.6% annually. These numbers still trail higher-growth peers. A significant $787 million one-off loss in the last twelve months has weighed on reported earnings and margin quality. Investors...
NasdaqCM:ALDX
NasdaqCM:ALDXBiotechs

High Growth Tech Stocks In The US Market With Promising Potential

Amid a backdrop of record highs in major stock indexes and anticipation surrounding the Federal Reserve's interest rate decisions, the U.S. market is witnessing a dynamic phase where tech stocks are capturing significant attention. In this environment, identifying high growth potential often involves looking at companies that can leverage technological advancements like AI to drive innovation and expansion.
NYSE:DEA
NYSE:DEAOffice REITs

Easterly Government Properties (DEA) Margin Decline Reinforces Cautious Growth Narrative Heading Into Earnings

Easterly Government Properties (DEA) is forecasting revenue growth of 6.4% per year, which trails the US market's average of 10.1%. Earnings are expected to inch up by 2.4% annually, also lagging the market average of 15.5%. After a year of negative earnings growth and a slip in net profit margins from 6.2% to 5.2%, investors will be weighing the significance of muted growth forecasts, elevated valuation multiples, and ongoing financial risks as the company's earnings results come into...
NasdaqCM:SMLR
NasdaqCM:SMLRMedical Equipment

Can Semler Scientific's (SMLR) Dual Leadership Structure Sustain Long-Term Management Credibility?

On October 16, 2025, Semler Scientific, Inc. announced that Chief Financial Officer Renae Cormier resigned to pursue another opportunity, effective October 30, 2025, with CEO Dr. Douglas Murphy-Chutorian appointed as interim CFO in addition to his current roles. This executive reorganization places both the chief executive and financial oversight responsibilities with one individual, which can draw investor scrutiny regarding management continuity and internal controls. We'll examine how the...